# Vyleesi (bremelanotide): Dosage, Side Effects & Uses

Source: https://pepvault.app/drugs/vyleesi

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Vyleesi

Brand-name drug · melanocortin receptor agonist

# Vyleesi (bremelanotide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Vyleesi is bremelanotide, the peptide known in research as PT-141, sold by Cosette Pharmaceuticals as a single-dose autoinjector used only when needed.

FDA approved it for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD): low sexual desire that causes marked distress or difficulty in a relationship and is not explained by another condition, relationship problems or a medicine.

- **Active ingredient:** [PT-141](https://pepvault.app/peptides/pt-141)
- **Maker:** Cosette Pharmaceuticals
- **Class:** melanocortin receptor agonist
- **FDA application:** [NDA 210557](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557), first approved 2019

## What FDA approved it for

Acquired means the low desire began after a time without problems; generalized means it happens regardless of situation or partner. The label rules out postmenopausal women and men, and says Vyleesi is not for enhancing sexual performance.

From the label: 2.1 Recommended Dosage; 1 Indications and Usage.

## How it is supplied

Vyleesi’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| Single-dose autoinjector | 1.75 mg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Vyleesi, as needed

Vyleesi, as needed: one dose on the label, 1.75 mg.

| Dose | When, on the label |
| --- | --- |
| 1.75 mg a dose | As needed, at least 45 minutes before sexual activity; at most one dose in 24 hours and 8 a month |

There is no climb: every dose is the same 1.75 mg, from the first. Few women in the trials used more than 8 doses a month, and the label adds that using it more often raises the chance of darkened skin patches and lengthens the time each month with raised blood pressure.

From the label: 2.1 Recommended Dosage.

## How it’s taken

Vyleesi is injected under the skin of the belly or thigh when needed, at least 45 minutes before expected sexual activity. The label says how long each dose works is unknown, and leaves the timing to each woman’s own experience of it.

The limits are firm: no more than one dose in 24 hours, because doses close together may add to the rise in blood pressure, and no more than 8 doses a month.

If there is no improvement after 8 weeks, the label says to stop.

From the label: 2.1 Recommended Dosage; 2.2 Discontinuation of VYLEESI.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

Vyleesi is used as needed, so its label has no missed-dose rule.

## Storage

Vyleesi is stored at or below 77°F, out of light, and never frozen.

From the label: 16 How Supplied / Storage and Handling.

## Side effects and warnings

Adverse reactions in at least 2% of women on Vyleesi and more often than on placebo, pooled phase 3 trials. Percent of people.

| Reaction | Placebo | 1.75 mg |
| --- | --- | --- |
| Nausea | 1.3 | 40.0 |
| Flushing | 0.3 | 20.3 |
| Injection site reactions | 8.4 | 13.2 |
| Headache | 1.9 | 11.3 |
| Vomiting | 0.2 | 4.8 |
| Cough | 1.3 | 3.3 |
| Fatigue | 0.5 | 3.2 |
| Hot flush | 0.2 | 2.7 |

Nausea was the most common reaction, in 40% against 1% on placebo; it usually began within an hour of the dose and lasted about two hours. In the trials, 18% stopped Vyleesi because of side effects, against 2% on placebo.

### The other warnings

Vyleesi has no boxed warning. Its label warns that each dose briefly raises blood pressure and lowers heart rate, peaking 2 to 4 hours after the dose, so it is not for people with uncontrolled high blood pressure or known heart disease. It also warns of darkened patches of skin (focal hyperpigmentation) and of nausea, and says to avoid naltrexone taken by mouth, whose levels Vyleesi can lower.

From the label: 6.1 Clinical Trials Experience; 5 Warnings and Precautions.

## What else we have on bremelanotide

### Bremelanotide on PepVault

- [PT-141 in the peptide library](https://pepvault.app/peptides/pt-141)
- [PT-141: half-life](https://pepvault.app/peptides/pt-141/half-life)
- [PT-141: side effects](https://pepvault.app/peptides/pt-141/side-effects)
- [PT-141: how long it takes to work](https://pepvault.app/peptides/pt-141/how-long-to-work)
- [Is PT-141 legal? FDA, DEA and WADA status](https://pepvault.app/peptides/pt-141/legal-status)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016)
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022)
- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)

### Compound against compound

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)

## Questions about Vyleesi

### What is the dose of Vyleesi?

The label’s dose is 1.75 mg injected under the skin of the belly or thigh, as needed, at least 45 minutes before sexual activity. A prescriber decides whether it fits.

### How often can Vyleesi be used?

No more than one dose in 24 hours and no more than 8 doses a month, according to the label.

### Is Vyleesi the same as PT-141?

Vyleesi’s active ingredient is bremelanotide, the peptide known in research as PT-141; Vyleesi is the FDA-approved product made to its label.

### What is the most common side effect of Vyleesi?

Nausea, in 40% of women in the trials against 1% on placebo, usually starting within an hour and lasting about two hours.

### Is Vyleesi approved for men?

No. Its label says it is not for men or for postmenopausal women, and not for enhancing sexual performance.

## Sources

- [VYLEESI (bremelanotide injection), for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf) (version 2, published Nov 9, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 210557](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557) (Vyleesi, the autoinjector; application first approved 2019)

PepVault is not affiliated with Cosette Pharmaceuticals. Vyleesi is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on bremelanotide

### Bremelanotide on PepVault

- [PT-141 in the peptide library](https://pepvault.app/peptides/pt-141)
- [PT-141: half-life](https://pepvault.app/peptides/pt-141/half-life)
- [PT-141: side effects](https://pepvault.app/peptides/pt-141/side-effects)
- [PT-141: how long it takes to work](https://pepvault.app/peptides/pt-141/how-long-to-work)
- [Is PT-141 legal? FDA, DEA and WADA status](https://pepvault.app/peptides/pt-141/legal-status)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016)
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022)
- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)

## The library

- [PT-141 in the peptide library](https://pepvault.app/peptides/pt-141)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Cosette Pharmaceuticals. Vyleesi is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
